Trial Profile
An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs AKF 1 (Primary)
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- Sponsors Akorn
- 27 Nov 2015 New trial record